Results for tag: "Fibrinogen Concentrates"

Fibrinogen Concentrates are a type of Hematological Drug used to treat bleeding disorders caused by a deficiency of fibrinogen, a protein in the blood that helps form blood clots. Fibrinogen Concentrates are derived from human plasma and are used to replace the missing fibrinogen in patients with congenital or acquired fibrinogen deficiency. The drug is administered intravenously and is used to treat bleeding episodes, as well as to prevent bleeding during surgery. The Fibrinogen Concentrates market is expected to grow due to the increasing prevalence of bleeding disorders, the rising demand for blood products, and the growing number of surgical procedures. Additionally, the development of new products and the increasing availability of generic drugs are expected to drive the market. Some of the major companies in the Fibrinogen Concentrates market include CSL Behring, Grifols, Octapharma, Kedrion, and Shire. Show Less Read more